| Molecular properties of WHO essential drugs and provisional biopharmaceutical classification NA Kasim, M Whitehouse, C Ramachandran, M Bermejo, H Lennernäs, ... Molecular pharmaceutics 1 (1), 85-96, 2004 | 825 | 2004 |
| Biopharmaceutics classification system: the scientific basis for biowaiver extensions LX Yu, GL Amidon, JE Polli, H Zhao, MU Mehta, DP Conner, VP Shah, ... Pharmaceutical research 19 (7), 921-925, 2002 | 659 | 2002 |
| FIP/AAPS guidelines to dissolution/in vitro release testing of novel/special dosage forms M Siewert, J Dressman, CK Brown, VP Shah, JM Aiache, N Aoyagi, ... AAPS PharmSciTech 4 (1), 43-52, 2003 | 377 | 2003 |
| Applications of process analytical technology to crystallization processes XY Lawrence, RA Lionberger, AS Raw, R D'Costa, H Wu, AS Hussain Advanced Drug Delivery Reviews 56 (3), 349-369, 2004 | 327 | 2004 |
| Transdermal drug delivery system (TDDS) adhesion as a critical safety, efficacy and quality attribute AM Wokovich, S Prodduturi, WH Doub, AS Hussain, LF Buhse European journal of pharmaceutics and biopharmaceutics 64 (1), 1-8, 2006 | 261 | 2006 |
| Bioavailability and bioequivalence: an FDA regulatory overview ML Chen, V Shah, R Patnaik, W Adams, A Hussain, D Conner, M Mehta, ... Pharmaceutical research 18 (12), 1645-1650, 2001 | 199 | 2001 |
| Application of neural computing in pharmaceutical product development AS Hussain, X Yu, RD Johnson Pharmaceutical research 8 (10), 1248-1252, 1991 | 190 | 1991 |
| Effect of common excipients on Caco‐2 transport of low‐permeability drugs BD Rege, LX Yu, AS Hussain, JE Polli Journal of pharmaceutical sciences 90 (11), 1776-1786, 2001 | 187 | 2001 |
| Polymer erosion and drug release characterization of hydroxypropyl hethylcellulose matrices TD Reynolds, SH Gehrke, AS Hussain, LS Shenouda Journal of pharmaceutical sciences 87 (9), 1115-1123, 1998 | 185 | 1998 |
| Near-infrared spectral imaging for quality assurance of pharmaceutical products: analysis of tablets to assess powder blend homogeneity RC Lyon, DS Lester, EN Lewis, E Lee, XY Lawrence, EH Jefferson, ... AAPS PharmSciTech 3 (3), 1-15, 2002 | 177 | 2002 |
| Feasibility studies of utilizing disk intrinsic dissolution rate to classify drugs XY Lawrence, AS Carlin, GL Amidon, AS Hussain International journal of pharmaceutics 270 (1-2), 221-227, 2004 | 172 | 2004 |
| Summary workshop report: biopharmaceutics classification system—implementation challenges and extension opportunities JE Polli, LX Yu, JA Cook, GL Amidon, RT Borchardt, BA Burnside, ... Journal of pharmaceutical sciences 93 (6), 1375-1381, 2004 | 149 | 2004 |
| Identification of critical formulation and processing variables for metoprolol tartrate extended-release (ER) matrix tablets GS Rekhi, RV Nellore, AS Hussain, LG Tillman, HJ Malinowski, ... Journal of controlled release 59 (3), 327-342, 1999 | 137 | 1999 |
| Scientific considerations of pharmaceutical solid polymorphism in abbreviated new drug applications XY Lawrence, MS Furness, A Raw, KPW Outlaw, NE Nashed, E Ramos, ... Pharmaceutical Research 20 (4), 531-536, 2003 | 119 | 2003 |
| Development of metoprolol tartrate extended-release matrix tablet formulations for regulatory policy consideration RV Nellore, GS Rekhi, AS Hussain, LG Tillman, LL Augsburger Journal of controlled release 50 (1-3), 247-256, 1998 | 114 | 1998 |
| Stability profiles of drug products extended beyond labeled expiration dates RC Lyon, JS Taylor, DA Porter, HR Prasanna, AS Hussain Journal of pharmaceutical sciences 95 (7), 1549-1560, 2006 | 100 | 2006 |
| Quantitative determination of cesium binding to ferric hexacyanoferrate: Prussian blue PJ Faustino, Y Yang, JJ Progar, CR Brownell, N Sadrieh, JC May, ... Journal of pharmaceutical and biomedical analysis 47 (1), 114-125, 2008 | 99 | 2008 |
| Development and internal validation of an in vitro-in vivo correlation for a hydrophilic metoprolol tartrate extended release tablet formulation ND Eddington, P Marroum, R Uppoor, A Hussain, L Augsburger Pharmaceutical research 15 (3), 466-473, 1998 | 88 | 1998 |
| Assuring quality and performance of sustained and controlled release parenterals: AAPS workshop report, co-sponsored by FDA and USP DJ Burgess, AS Hussain, TS Ingallinera, ML Chen Pharmaceutical research 19 (11), 1761-1768, 2002 | 86* | 2002 |
| Assuring quality and performance of sustained and controlled release parenterals: EUFEPS workshop report DJ Burgess, DJA Crommelin, AS Hussain, ML Chen AAPS PharmSci 6 (1), 100-111, 2004 | 83 | 2004 |
Lawrence YuFood and Drug AdministrationVerified email at fda.hhs.gov
